ICU liver patients: new study tests HLH diagnostic tool
NCT ID NCT07343037
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a tool called the HScore can accurately diagnose hemophagocytic lymphohistiocytosis (HLH) in intensive care patients with liver failure or cirrhosis. Researchers will review medical records of 100 adults admitted to one hospital over ten years who had certain blood test abnormalities. The goal is to find the best way to identify HLH in this high-risk group.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS, LIVER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Médecine intensive - Réanimation - CHU de Strasbourg - France
RECRUITINGStrasbourg, 67091, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Liver function and drug dosing: a closer look at ulonivirine
- Liver function may change how mavorixafor works in the body
- Decade-Long study aims to unlock liver disease risks in HIV-Hepatitis b patients
- Zambia study tracks hepatitis b outcomes in hundreds of patients
- New cholesterol drug tested in liver patients
- New study tracks blood sugar in liver disease patients on common drug